AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figures on a giant magnifying glass look at a document

Behind Oregon’s first-in-nation law curbing corporate medicine

| 5 Min Read
Smiling patient with doctor

CEOs push physician well-being from perk to performance goal

| 8 Min Read
Team of doctors discussing over x-ray report

8 health systems finding success in physician recruitment, retention

| 8 Min Read
Columns of the U.S. Supreme Court at top of steps

8 wins for doctors, patients in latest federal budget deal

| 4 Min Read